CONGRESS PROGRAM
08:00
Registration
09:00
Welcome and Opening of the Congress
Jacob Ablin, Israel and Piercarlo Sarzi-Puttini, Italy
09:10
Session 1: To be or not to be (a separate syndrome)? The fibromyalgia conundrum in a nociplastic world of pain
09:10-09:30
Year in review: Fibromyalgia and chronic pain
Valeria Giorgi
IRCCS Galeazzi - Sant'Ambrogio, Milan, Italy
09:30-09:50
What's new with chronic fatigue? Insights into mechanisms of fatigue in a post – COVID era
Piercarlo Sarzi-Puttini
IRCCS Ospedale Galeazzi – Sant'Ambrogio, Italy
09:50-10:30
Keynote Lecture: Overview of nociplastic pain / central sensitization
Eva Kosek
Karolinska Institute, Sweden
10:30
Networking, Coffee Break & Poster Viewing
11:00
Session 2: Why and how is this happening? A focus on pathogenesis
11:00-11:30
Cytokines and miRNA in chronic pain
Michaela Kress
Medical University Innsbruck, Austria
11:30-12:00
Fibromyalgia: Imbalance of Threat and Soothing Systems (FITSS)
José António P. Da Silva
University Hospital of Coimbra, Portugal
12:00
Session 3: Known knowns, known unknowns etc. Debatable mechanisms of chronic pain
12:00-12:30
Anti-satellite glia cell antibodies are associated with symptom severity in fibromyalgia
Camilla Svensson
Karolinska Institute, Sweden
12:30
Networking, Lunch Break & Poster Viewing
13:30
Session 4: Research frontiers in the understanding of fibromyalgia
13:30-14:10
Keynote Lecture: Genetic and epigenetics of fibromyalgia and chronic pain
Luda Diatchenko
McGill University, Canada
14:10-14:30
Role of Hyperalgesia in chronic widespread pain
Christopher Sivert Nielsen
Institute of Public Health, Norway
14:30-14:50
Insights from the field of sleep (
Pre-Recorded)
Pre-Recorded) 
Liborio Parrino
Parma University Hospital, Italy
14:50-15:10
The evolving role of small fiber neuropathy in fibromyalgia
Andrea Truini
Sapienza University of Rome, Italy
15:10
Networking, Coffee Break & Poster Viewing
15:40
Session 5: Meanwhile, back in the clinic… A focus on clinical topics in the management of fibromyalgia patients
15:40-16:00
The transition to chronic pain: Risk factors and potential for prevention
Valerie Aloush
Tel Aviv Sourasky Medical Center, Israel
16:00-16:20
Obesity, bariatric surgery, and chronic pain
Fabiola Atzeni
University of Messina, Italy
16:20-16:40
Sexuality and fibromyalgia. A call for dialogue
Cristina Iannuccelli
Sapienza University of Rome, Italy
16:40
Oral Presentations of Selected Abstracts
16:40-16:50
Comorbid Associations in Fibromyalgia. Looking Beyond Irritable Bowel Syndrome: Findings from an Investigation into Fibromyalgia, Digestive Function and the Microbiome of the Gastrointestingal Tract (The FIDGIT Study)
16:50-17:00
Alexithymia and psychological distress in fibromyalgia and chronic migraine: Clues for nociplastic pain conditions?
17:00-17:10
Group therapy for Fibromyalgia: A randomized controlled trial of mindfulness-based therapy versus cognitive-behavioral therapy
17:10-17:20
Efficacy and Safety of TNX-102 SL (Sublingual Cyclobenzaprine) for the Treatment of Fibromyalgia: Results from the Randomized, Placebo Controlled RELIEF Trial
17:20-17:30
Discussion
17:30
End of Day One
08:30
Registration
09:00
Session 6: What's new in the other nociplastic syndromes?
09:00-09:20
Gut feelings: IBS revisited
David Bulmer
University of Cambridge, UK
09:20-09:40
From Long COVID to fibromyalgia: insights from an evolving trajectory
Jacob Ablin
Tel-Aviv Sourasky Medical Center, Israel
09:40-10:10
Keynote Lecture: Neuro-immune mechanisms of pain in Fibromyalgia
Shafaq Sikandar
Queen Mary University of London, UK
10:10
Session 7: Primary, secondary, concomitant and everything in between. The interaction of chronic pain with inflammatory and non-inflammatory comorbidities
10:10-10:30
Sjogren syndrome and fibromyalgia
Luca Quartuccio
University of Udine, Italy
10:30
Networking, Coffee Break & Poster Viewing
11:00
Session 7: Primary, secondary, concomitant and everything in between. The interaction of chronic pain with inflammatory and non-inflammatory comorbidities (continued)
11:00-11:20
SLE and chronic pain
Sara Bindoli
Padova University Hospital, Italy
11:20-11:40
From painful joints to widespread pain: why is fibromyalgia so common in Rheumatoid arthritis? ( Pre-Recorded)
Pre-Recorded) 
Ernest Choy
Cardiff University School of Medicine, Cardiff, Wales, UK
11:40
Session 8: Can we get there without drugs? Exploring non- pharmacological approaches to treating fibromyalgia
11:40-12:20
Taking a closer look at the use of hyperbaric oxygen therapy for fibromyalgia
Shai Efrati
Shamir (Assaf-Harofeh) Medical Center & Tel Aviv University, Israel
12:20-12:50
Manipulating the microbiome for chronic pain: the case for fecal transplant
Amir Minerbi
Rambam Health Care Campus, Israel
12:50
Networking, Lunch Break & Poster Viewing
13:50
Session 9: So, is anything new on the pharmacological front?
13:50-14:10
The ongoing role of anti-depressants and anti – convulsants in fibromyalgia ( Pre-Recorded)
Pre-Recorded) 
Winfried Häuser
Klinikum Saarbrücken, Germany
14:10-14:30
The ongoing cannabinoid saga in the treatment of fibromyalgia and chronic pain
Gilat Shenhav
Laniado Hospital, Israel
14:30-14:50
Rational implementation of Jak inhibitors and other biologics in treating chronic pain and fatigue in rheumatoid arthritis
Piercarlo Sarzi-Puttini
IRCCS Ospedale Galeazzi – Sant'Ambrogio, Italy
14:50-15:10
L-acetyl carnitine (LAC) and Palmitoylethanolamide (PEA): Nutritional supplements in the struggle against chronic pain
Enrico Polati
University Hospital of Verona, Italy
15:10
Networking, Coffee Break & Poster Viewing
15:40
Session 10: Registries, patient associations and the holy grail of prevention
15:40-15:55
The role of Registries in Fibromyalgia
Marco Di Carlo
Polytechnic University of Marche, Italy
15:55-16:10
Classifying (and misclassifying) fibromyalgia: why definitions make a difference ( Pre-Recorded)
Pre-Recorded)
Winfried Häuser
Klinikum Saarbrücken, Germany
16:10-16:40
Patient centered care for fibromyalgia - PACFiND program
Gary J. Macfarlane
University of Aberdeen, UK
16:40-17:00
The role of patient associations
Giuseppina Fabio
AISF ODV (Italian Association of Fibromyalgia Syndrome), Italy
17:00
Congress Closing Remarks
Jacob Ablin, Israel and Piercarlo Sarzi-Puttini, Italy
17:10
End of Congress